Organization
Hospital Vall d'Hebron, Barcelona, Spain
2 abstracts
Abstract
ADRIATIC: Durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC).Org: Sarah Cannon Research Institute/Tennessee Oncology, Jilin Cancer Hospital, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea, Federal State Budgetary Institution “N. N. Blokhin National Medical Research Center of Oncology” of the Ministry of Health of the Russian Federation (N.N. Blokhin NMRCO), Beijing Cancer Hospital,
Abstract
B-CELL LYMPHOPROLIFERATION IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION ASSOCIATED WITH SJÖGREN SYNDROMEOrg: Hospital Clinic, Barcelona, Spain, Internal Medicine Unit, S. Martino Hospital, Oristano, Clinic of Rheumatology, University of Udine, Udine, Italy, Hospital Vall d'Hebron, Barcelona, Spain, University of Modena, Modena, Italy,